Associate Professor, Medicine, USC School of Medicine
Oncology
Dr. Agustin A. Garcia, MD
|
|
Give Review
Agustin Garcia practices Oncology. He graduated from Universidad Anahuac School of Medicine. Dr. Agustin A. Garcia is also published. He has 26 publications published. The lastest publication: "Phase I clinical trial of temsirolimus and vinorelbine in advanced solid tumors.' Agustin A. Garcia is registered with Medicare.
Publications
- Phase I clinical trial of temsirolimus and vinorelbine in advanced solid Tumors.
- Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast Cancer: a randomised phase 2 study.
- Randomized Multicenter Phase II Trial Comparing Two Schedules of Etirinotecan Pegol (NKTR-102) in Women With Recurrent Platinum-Resistant/Refractory Epithelial Ovarian...
- Bevacizumab and ovarian Cancer.
- Phase II Study of Gemcitabine and Docetaxel in Recurrent Platinum Resistant Ovarian Cancer.
- A phase II evaluation of lapatinib in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal Carcinoma: A gynecologic oncology group study.
- Phase I clinical trial of pegylated liposomal Doxorubicin and docetaxel in patients with advanced solid Tumors.
- A phase I trial of dose-dense (biweekly) carboplatin combined with paclitaxel and pegfilgrastim: a feasibility study in patients with untreated Stage III and IV ovaria...
- Fixed-dose rate gemcitabine plus carboplatin in relapsed, platinum-sensitive ovarian Cancer patients: results of a three-arm Phase I study.
- Polymorphisms and clinical outcome in recurrent ovarian Cancer treated with cyclophosphamide and bevacizumab.
- Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian Cancer: a trial of the California, Chicago, and Princess Marg...
- Current status of signal transduction modulators in the treatment of gynecologic Malignancies.
- Phase II clinical trial of capecitabine in the treatment of advanced, persistent or recurrent squamous cell Carcinoma of the cervix with translational research: a gyne...
- Clinical activity of pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in advanced ovarian Cancer: potential predictive relationship with tumor HER2 activation st...
- Phase I clinical trial of weekly docetaxel and exisulind, a novel inducer of apoptosis.
- Phase I clinical trial of topotecan and pegylated liposomal doxorubicin.
- Phase II study of gemcitabine and weekly paclitaxel in recurrent platinum-resistant ovarian Cancer.
- Phase II clinical trial of 5-fluorouracil, trimetrexate, and leucovorin (NFL) in patients with advanced pancreatic Cancer.
- Update on aromatase inhibitors in breast Cancer.
- Bevacizumab in the management of solid Tumors.
- Phase I escalation of gemcitabine combined with proTracted oral etoposide in gynecologic malignancies: A Gynecologic Oncology Group study.
- Phase I clinical and pharmacokinetic trial of docetaxel and irinotecan administered on a weekly schedule.
- Phase II clinical trial of capecitabine in ovarian Carcinoma recurrent 6-12 months after completion of primary chemotherapy, with exploratory TS, DPD, and TP correlate...
- Phase II clinical trial of docetaxel in refractory squamous cell Carcinoma of the cervix: a Gynecologic Oncology Group Study.
- A phase II evaluation of weekly docetaxel in the treatment of recurrent or persistent endometrial Carcinoma: a study by the Gynecologic Oncology Group.
Schools
Universidad Anahuac Escuela De Medicina
L a Co Usc Med Center
University Il College Med Urbana
Procedures Preformed
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Oncology
Accepted Insurances
Education
-
University of Southern California - LAC+USC Medical Center -
Universidad Anahuac School of Medicine
Hospital
-
Ronald Reagan UCLA Medical Center -
Keck Hospital of USC
Drug Facts
| NPI NUMBER | 1942258116 | |
| NPPES Provider LastName | GARCIA | |
| NPPES Provider FirstName | AGUSTIN | |
| NPPES Provider ZIPCode | 900890112 | |
| NPPES Provider State | CA | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 307.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1942258116 |
| Last Name Of The Provider | GARCIA |
| First Name Of The Provider | AGUSTIN |
| View All |
Similar Doctors
|
Dr. John L. Barstis, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Dennis R. Holmes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fariborz Mortazavi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jacek K. Pinski, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dennis J. Slamon, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|